Envigo Rat Models Proven to be Susceptible to Intra-Vaginal HSV-2 Infection and Protectable by Attenuated HSV-1 Against Symptomatic HSV-2
Scientific findings establish the effectiveness of Envigo’s new approach to investigate the protective effects of vaccine candidates and anti-viral microbodies and to study asymptomatic primary genital HSV-2 infection